Published in Women's Health Weekly, September 4th, 2003
According to published research from Switzerland, "Cyclin E amplification and overexpression have recently been described in several tumor types. However, many tumor entities have never been examined for cyclin E alterations.
"Numerous and time-consuming experiments were previously required to determine the significance of potential oncogenes across different tumor types," wrote P. Schraml and colleagues, University of Basel Hospital, Pathology Institute.
"To overcome this problem, tissue microarrays (TMAs) consisting of 3670 primary tumors from 128...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly